Effect of intravenous ghrelin administration, combined with alcohol, on circulating metabolome in heavy drinking individuals with alcohol use disorder

What Was Tested

This randomized controlled trial paper looks at Ghrelin.

The aim of this exploratory analysis was to investigate associations between ghrelin administration and the human circulating metabolome during alcohol exposure in nontreatment seeking, heavy drinking individuals with alcohol use disorder (AUD).

Why It Was Studied

Ghrelin may influence several alcohol-related behaviors in animals and humans by modulating central and/or peripheral biological pathways.

Who Took Part

The age groups tagged for this paper are adults, men only.

The researchers used serum samples from a randomized, crossover, double-blind, placebo-controlled human laboratory study with intravenous (IV) ghrelin or placebo infusion in two experiments.

The first experiment included an IV alcohol self-administration (IV-ASA) session and the second experiment included an IV alcohol clamp (IV-AC) session, both with the counterbalanced infusion of ghrelin or placebo.

How the Study Was Run

The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.

Because people in this Ghrelin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the participants nor the staff measuring them knew who was on Ghrelin, so expectations could not easily colour the readings.

A placebo (an inactive look-alike) gave the Ghrelin group a baseline to be compared against.

In the crossover set-up each of the participants took both Ghrelin and the comparison in turn, acting as their own control.

Serum metabolite profiles were analyzed from repeated blood samples collected during each session.

What Was Measured

The subject headings attached to it are Alcohol Drinking, Alcoholism, Central Nervous System Stimulants, Craving, Ethanol and Ghrelin.

Author keywords: alcohol use disorder, bile acids, corticosteroids and metabolomics.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Ghrelin.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2021 (Alcoholism, clinical and experimental research), a journal based in England.

More context: the Ghrelin compound page, all human trials.